ganirelix [3609]
ganirelix
| SMILES | CCN=C(NCC)NCCCCC(NC(=O)C(CC(C)C)NC(=O)C(CCCCN=C(NCC)NCC)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1cccnc1)NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)C(Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCCC1C(=O)NC(C)C(N)=O |
| InChIKey | GJNXBNATEDXMAK-UHFFFAOYSA-N |
| Sequence | AFASYXLXPA |
| HELM | PEPTIDE1{[ac].[*C(=O)C(Cc1ccc2ccccc2c1)N* |$_R2;;;;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1ccc(cc1)Cl)N* |$_R2;;;;;;;;;;;;;_R1$|].[*C(=O)[C@H](Cc1cccnc1)N* |$_R2;;;;;;;;;;;;_R1$|].[dS].[dY].[*C(=O)[C@@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].L.[*C(=O)[C@H](CCCCN=C(NCC)NCC)N* |$_R2;;;;;;;;;;;;;;;;;_R1$|].(P,[dP]).[dA].[am]}$$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
No bioactivity data available.
ganirelix
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|